10X Genomics Hits New 52-Week High of $26.44, Reflecting Strong Growth
10X Genomics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. The company, with a market capitalization of USD 2,132 million, has seen a 17.58% performance rise over the past year, despite being loss-making and not offering dividends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)